Benjamin Paluch

Stock Analyst at Roth MKM

(1.54)

# 3,231

Out of 4,740 analysts

3

Total ratings

66.67%

Success rate

-0.53%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$30.21	+115.16%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$13.02	+30.57%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$3.15	+217.46%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $30.21

Upside: +115.16%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $13.02

Upside: +30.57%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $3.15

Upside: +217.46%